OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
microRNAs as cancer therapeutics: A step closer to clinical application
Tina Catela Ivković, Gjendine Voss, Helena Cornellà, et al.
Cancer Letters (2017) Vol. 407, pp. 113-122
Closed Access | Times Cited: 126
Tina Catela Ivković, Gjendine Voss, Helena Cornellà, et al.
Cancer Letters (2017) Vol. 407, pp. 113-122
Closed Access | Times Cited: 126
Showing 1-25 of 126 citing articles:
PD-1/PD-L1 pathway: current researches in cancer.
Yanyan Han, Dandan Liu, Lianhong Li
PubMed (2020) Vol. 10, Iss. 3, pp. 727-742
Closed Access | Times Cited: 1350
Yanyan Han, Dandan Liu, Lianhong Li
PubMed (2020) Vol. 10, Iss. 3, pp. 727-742
Closed Access | Times Cited: 1350
miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges
Shanshan Zhou, Jing-peng Jin, Jiqun Wang, et al.
Acta Pharmacologica Sinica (2018) Vol. 39, Iss. 7, pp. 1073-1084
Open Access | Times Cited: 552
Shanshan Zhou, Jing-peng Jin, Jiqun Wang, et al.
Acta Pharmacologica Sinica (2018) Vol. 39, Iss. 7, pp. 1073-1084
Open Access | Times Cited: 552
The clinical potential of circulating microRNAs in obesity
Chenbo Ji, Xirong Guo
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 12, pp. 731-743
Closed Access | Times Cited: 222
Chenbo Ji, Xirong Guo
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 12, pp. 731-743
Closed Access | Times Cited: 222
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Recep Bayraktar, Katrien Van Roosbroeck
Cancer and Metastasis Reviews (2017) Vol. 37, Iss. 1, pp. 33-44
Closed Access | Times Cited: 190
Recep Bayraktar, Katrien Van Roosbroeck
Cancer and Metastasis Reviews (2017) Vol. 37, Iss. 1, pp. 33-44
Closed Access | Times Cited: 190
miR-155: An Important Role in Inflammation Response
Jingyan Hu, Songli Huang, Xiaoli Liu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 85
Jingyan Hu, Songli Huang, Xiaoli Liu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 85
miRNAs as cornerstones in adipogenesis and obesity
Samy Y. Elkhawaga, Ahmed Ismail, Elsayed G.E. Elsakka, et al.
Life Sciences (2023) Vol. 315, pp. 121382-121382
Closed Access | Times Cited: 67
Samy Y. Elkhawaga, Ahmed Ismail, Elsayed G.E. Elsakka, et al.
Life Sciences (2023) Vol. 315, pp. 121382-121382
Closed Access | Times Cited: 67
The Dual Role of MicroRNAs in Colorectal Cancer Progression
Lei Ding, Zhenwei Lan, Xianhui Xiong, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2791-2791
Open Access | Times Cited: 110
Lei Ding, Zhenwei Lan, Xianhui Xiong, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2791-2791
Open Access | Times Cited: 110
Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer
Yusuke Goto, Akira Kurozumi, Takayuki Arai, et al.
British Journal of Cancer (2017) Vol. 117, Iss. 3, pp. 409-420
Open Access | Times Cited: 103
Yusuke Goto, Akira Kurozumi, Takayuki Arai, et al.
British Journal of Cancer (2017) Vol. 117, Iss. 3, pp. 409-420
Open Access | Times Cited: 103
Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
Yang Li, Yanhong Duo, Jiangang Bi, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 1241-1256
Open Access | Times Cited: 103
Yang Li, Yanhong Duo, Jiangang Bi, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 1241-1256
Open Access | Times Cited: 103
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model
Elisa Callegari, Lucilla D’Abundo, Paola Guerriero, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 11, pp. 485-493
Open Access | Times Cited: 89
Elisa Callegari, Lucilla D’Abundo, Paola Guerriero, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 11, pp. 485-493
Open Access | Times Cited: 89
siRNA- and miRNA-based therapeutics for liver fibrosis
Zhen Zhao, Chien–Yu Lin, Kun Cheng
Translational research (2019) Vol. 214, pp. 17-29
Open Access | Times Cited: 89
Zhen Zhao, Chien–Yu Lin, Kun Cheng
Translational research (2019) Vol. 214, pp. 17-29
Open Access | Times Cited: 89
Small non‐coding RNA and colorectal cancer
Hui Chen, Zhiying Xu, Deliang Liu
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 5, pp. 3050-3057
Open Access | Times Cited: 85
Hui Chen, Zhiying Xu, Deliang Liu
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 5, pp. 3050-3057
Open Access | Times Cited: 85
GRSF1-mediatedMIR-G-1promotes malignant behavior and nuclear autophagy by directly upregulatingTMED5andLMNB1in cervical cancer cells
Zhen Yang, Qi Sun, Junfei Guo, et al.
Autophagy (2018) Vol. 15, Iss. 4, pp. 668-685
Open Access | Times Cited: 83
Zhen Yang, Qi Sun, Junfei Guo, et al.
Autophagy (2018) Vol. 15, Iss. 4, pp. 668-685
Open Access | Times Cited: 83
MicroRNAs in cancer metastasis: biological and therapeutic implications
Marie C. Sell, Charmaine A. Ramlogan‐Steel, Jason C. Steel, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 26
Marie C. Sell, Charmaine A. Ramlogan‐Steel, Jason C. Steel, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 26
MicroRNAs and Cancer: A Long Story for Short RNAs
Alessandra Drusco, Carlo M. Croce
Advances in cancer research (2017), pp. 1-24
Closed Access | Times Cited: 80
Alessandra Drusco, Carlo M. Croce
Advances in cancer research (2017), pp. 1-24
Closed Access | Times Cited: 80
Nucleic acids delivering nucleic acids
Silvia Catuogno, Carla Lucia Esposito, Gerolama Condorelli, et al.
Advanced Drug Delivery Reviews (2018) Vol. 134, pp. 79-93
Closed Access | Times Cited: 61
Silvia Catuogno, Carla Lucia Esposito, Gerolama Condorelli, et al.
Advanced Drug Delivery Reviews (2018) Vol. 134, pp. 79-93
Closed Access | Times Cited: 61
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Xiaolong Liu, Shuang Liu, Hui Lyu, et al.
Biological Procedures Online (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 61
Xiaolong Liu, Shuang Liu, Hui Lyu, et al.
Biological Procedures Online (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 61
The Role of miR-155 in Antitumor Immunity
Katerina Kalkusova, Pavla Táborská, Dmitry Stakheev, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5414-5414
Open Access | Times Cited: 30
Katerina Kalkusova, Pavla Táborská, Dmitry Stakheev, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5414-5414
Open Access | Times Cited: 30
miRNAs as Potential Treatment Targets and Treatment Options in Cancer
Nina Petrović, Sercan Ergün
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 2, pp. 157-168
Open Access | Times Cited: 52
Nina Petrović, Sercan Ergün
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 2, pp. 157-168
Open Access | Times Cited: 52
Regulatory Mechanisms of Soft Palate Development and Malformations
Jiaxi Li, Gabriela Rodriguez, Xia Han, et al.
Journal of Dental Research (2019) Vol. 98, Iss. 9, pp. 959-967
Open Access | Times Cited: 52
Jiaxi Li, Gabriela Rodriguez, Xia Han, et al.
Journal of Dental Research (2019) Vol. 98, Iss. 9, pp. 959-967
Open Access | Times Cited: 52
Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer
Hui Lyu, Shuiliang Wang, Jingcao Huang, et al.
Cancer Letters (2018) Vol. 420, pp. 97-108
Open Access | Times Cited: 49
Hui Lyu, Shuiliang Wang, Jingcao Huang, et al.
Cancer Letters (2018) Vol. 420, pp. 97-108
Open Access | Times Cited: 49
Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α
Yongxin Qiu, Wenqi Shan, Ye Yang, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 47
Yongxin Qiu, Wenqi Shan, Ye Yang, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 47
Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential
Dongsong Nie, Jiewen Fu, Hanchun Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 861-861
Open Access | Times Cited: 45
Dongsong Nie, Jiewen Fu, Hanchun Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 861-861
Open Access | Times Cited: 45
The Molecular Mechanisms and Function of miR-15a/16 Dysregulation in Fibrotic Diseases
Dada Wen, Huamin Zhang, Yutong Zhou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16041-16041
Open Access | Times Cited: 26
Dada Wen, Huamin Zhang, Yutong Zhou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16041-16041
Open Access | Times Cited: 26
Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma
Aya Salman, Sherif S. Abdel Mageed, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154947-154947
Closed Access | Times Cited: 15
Aya Salman, Sherif S. Abdel Mageed, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154947-154947
Closed Access | Times Cited: 15
